MDS Pharma Services – The world's premier provider of innovative drug discovery and development solutions. We offer a full spectrum of world-class discovery, preclinical and clinical resources and expertise, strategically located around the world, to meet the needs of the global pharmaceutical and biotech industries. Our broad range of services is designed to increase the speed, precision and productivity of your drug discovery and development activities. Through 2009 and 2010, MDS Inc. divested the assets of MDS Pharma Services: - The former discovery and preclinical businesses (Pharmacology/DMPK and Drug Safety Assessment) have been acquired by Ricerca Biosciences LLC. - The former early stage clinical research operations (the Development & Regulatory Services consultancy and Early Stage Development business) have been acquired by Celerion Inc. - The former late stage clinical research operations (Global Clinical Development) have been acquired by INC Research. - The former clinical laboratory operations (Global Clinical Development) have been acquired by Clearstone Central Laboratories..
There is no investment information
No recent news or press coverage available for MDS Pharma Services.
We care about your data, and we'd love to use cookies make your experience better.
